Molybdenum trisulfide
Small moleculeexperimental
Molybdenum trisulfide is an inorganic compound with the formula MoS3. — Wikipedia
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04046978)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMolybdenum trisulfide ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04046978 | N/A | Sep 30, 2019 | European Commission, Imperial College London, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Commission | Government | 1 | 0 | 1 | 2019 |
| Imperial College London | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1